Pages that link to "Item:Q1658329"
From MaRDI portal
The following pages link to Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials (Q1658329):
Displaying 8 items.
- Center-within-trial versus trial-level evaluation of surrogate endpoints (Q1623614) (← links)
- Statistical evaluation of surrogate endpoints with examples from cancer clinical trials (Q2792764) (← links)
- Meta-analysis for surrogacy: accelerated failure time models and semicompeting risks modeling (Q2894010) (← links)
- Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials (Q3842893) (← links)
- Analyzing survival data in conjunction with time-dependent surrogate endpoints in clinical trials (Q4337068) (← links)
- Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy (Q6055756) (← links)
- A joint frailty‐copula model for meta‐analytic validation of failure time surrogate endpoints in clinical trials (Q6071311) (← links)
- One-step validation method for surrogate endpoints using data from multiple randomized cancer clinical trials with failure-time endpoints (Q6624663) (← links)